← United States · All US Insider Profiles
US INSIDER PROFILE · NON-SCORING RESEARCH
Kosasa Thomas
10% Owner | Director
Identity: SEC owner CIK matched through an unambiguous cached owner-name crosswalk · Reporting-owner CIK: 0001989846
Purchase history
- Companies traded
- 1
- Purchases · 12M
- 6
- Purchases · 24M
- 6
- Average purchase
- $566.6K
- Median purchase
- $500.0K
- Gross purchase value
- $3.4M
Companies: OneMedNet Corp
6 SEC accession(s) · 0 joint-owner event(s). Values are reported Form 4 transaction values in USD.
Qualifying purchase disclosures
| Published | Company | Ticker | Role | Reported value | SEC source |
|---|---|---|---|---|---|
| 2026-10-13 | OneMedNet Corp | ONMD | Director | 10% Owner | $750.0K | Open filing |
| 2026-08-07 | OneMedNet Corp | ONMD | Director | 10% Owner | $1,000.0K | Open filing |
| 2026-06-15 | OneMedNet Corp | ONMD | Director | 10% Owner | $100.0K | Open filing |
| 2026-05-20 | OneMedNet Corp | ONMD | Director | 10% Owner | $250.0K | Open filing |
| 2026-04-24 | OneMedNet Corp | ONMD | Director | 10% Owner | $250.0K | Open filing |
| 2025-11-26 | OneMedNet Corp | ONMD | Director | $1.0M | Open filing |
Post-purchase outcomes
Excess return = stock return − S&P 500 ETF (SPY adjusted close) return. Returns start on the first shared trading session on or after publication.
| Period | Completed events | Price coverage | Hit rate | Median excess return | Average excess return | Worst excess return |
|---|---|---|---|---|---|---|
| 5D | 5Developing | 100.0% (5/5) | 60.0% (3/5) | +10.1% | +8.6% | -10.5% |
| 20D | 5Developing | 100.0% (5/5) | 40.0% (2/5) | -12.4% | -5.3% | -36.4% |
| 60D | 4Small Sample | 100.0% (4/4) | 25.0% (1/4) | -41.7% | -30.3% | -56.6% |
| 120D | 1Small Sample | 50.0% (1/2) | 0.0% (0/1) | -50.1% | -50.1% | -50.1% |
Research patterns
- First purchase in 12M
- 1/6
- Large purchase ≥ $100k
- 5/6
- Cluster buying · 15D
- 3/6
- Buying the dip
- 6/6
Routine / opportunistic: Not classifiable. These labels never affect the score or ranking.
Small samples remain visible but are not scored. This research enrichment never affects US-v1.1.